サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1178033

心血管診断・モニタリング装置の世界市場：製品別 - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 153 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心血管診断・モニタリング装置の世界市場：製品別 - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年11月25日
発行: Transparency Market Research
ページ情報: 英文 153 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の心血管診断・モニタリング装置市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、製品別・エンドユーザー別・地域別の分析、および競合情勢などを提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界の心血管診断・モニタリング装置市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の心血管診断・モニタリング装置市場の分析・予測（2017年～2031年）
  • ポーターのファイブフォース分析

第5章 主な洞察

  • 病気の有病率と発生率
  • 主要製品/ブランド分析
  • 心血管ケアにおけるスマートウェアラブルデバイス：現在の状況と今後の進展
  • バリューチェーン分析
  • COVID-19パンデミックの産業への影響（バリューチェーンと短期・中期・長期の影響）

第6章 世界の心血管診断・モニタリング装置市場の分析・予測：製品別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測、製品別（2017年～2031年）
    • ECGデバイス
    • ホルターモニター
    • イベントモニター
    • 埋め込み型ループレコーダー
    • モバイル心臓テレメトリー
  • 市場魅力分析、製品別

第7章 世界の心血管診断・モニタリング装置市場の分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測、エンドユーザー別（2017年～2031年）
    • 病院
    • 診療所
    • 外来手術センター
    • その他
  • 市場魅力分析、エンドユーザー別

第8章 世界の心血管診断・モニタリング装置市場の分析・予測：地域別

  • 主な調査結果
  • 市場金額予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析、地域別

第9章 北米の心血管診断・モニタリング装置市場の分析・予測

第10章 欧州の心血管診断・モニタリング装置市場の分析・予測

第11章 アジア太平洋の心血管診断・モニタリング装置市場の分析・予測

第12章 ラテンアメリカの心血管診断・モニタリング装置市場の分析・予測

第13章 中東・アフリカの心血管診断・モニタリング装置市場の分析・予測

第14章 競合情勢

  • 市場企業 - 競合マトリックス（ティア・企業規模別）
  • 市場シェア分析、企業別、2021年
  • 競争力のあるビジネス戦略
  • 企業プロファイル
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • GE Healthcare
    • Medtronic
    • Nihon Kohden Corporation
図表

List of Tables

  • Table 01: Global Stroke Incident Cases
  • Table 02: Global Prevalence of Heart Failure (2017)
  • Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016-2017
  • Table 04: Status of Cardiac Surgeries in North America
  • Table 05: New Zealand all cardiac surgery patients in 2016: age and gender
  • Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017
  • Table 07: Key Product/Brand Analysis of Implantable Loop Recorder
  • Table 08: Key Product/Brand Analysis of Holter Monitors
  • Table 09: Key Product/Brand Analysis of ECG
  • Table 10: Key Product/Brand Analysis of Event Monitors
  • Table 11: Key Product/Brand Analysis of Event Monitors
  • Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry
  • Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018
  • Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019
  • Table 15: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 16: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 17: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 20: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 22: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 35: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 36: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 37: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 38: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 39: GE Healthcare Business Overview
  • Table 40: Koninklijke Philips N.V. Business Overview
  • Table 41: Medtronic plc Business Overview
  • Table 42: Abbott Laboratories Business Overview
  • Table 43: Boston Scientific Corporation Business Overview
  • Table 44: Hill-Rom Holdings, Inc. Business Overview
  • Table 45: Nihon Kohden Corporation Business Overview
  • Table 46: Asahi Kasei Medical Co., Ltd. Business Overview

List of Figures

  • Figure 01: Global Cardiovascular Diagnostic & Monitoring Devices Market Share, by Type
  • Figure 02: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 03: Procedures performed in 2017 (New Zealand)
  • Figure 04: Procedures performed in 2017 (Australia)
  • Figure 05: Value Chain Analysis
  • Figure 06: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 07: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 08: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 09: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 10: Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis, by Region
  • Figure 11: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 12: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 13: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 15: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 16: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 17: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 18: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 20: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 22: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 31: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 32: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 33: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 36: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 37: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 38: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 39: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 40: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 41: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 43: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 44: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 45: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 46: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 47: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 48: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 49: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 50: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 51: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 52: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 53: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 54: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 55: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 56: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 57: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 58: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 59: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 60: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 61: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 62: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 63: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 64: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 65: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 66: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 67: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 68: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 69: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 70: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 71: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 72: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 73: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 74: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 75: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 76: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 77: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 78: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 79: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
目次
Product Code: TMRGL2385

TMR's report on the global cardiovascular diagnostic & monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cardiovascular diagnostic & monitoring devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiovascular diagnostic & monitoring devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiovascular diagnostic & monitoring devices market.

The report delves into the competitive landscape of the global cardiovascular diagnostic & monitoring devices market. Key players operating in the global cardiovascular diagnostic & monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cardiovascular diagnostic & monitoring devices market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiovascular Diagnostic & Monitoring Devices Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, 2017-2031
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate
  • 5.2. Key Product/Brand Analysis
  • 5.3. Smart wearable devices in cardiovascular care: where we are and how to move forward
  • 5.4. Value Chain Analysis
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. ECG Devices
      • 6.3.1.1. Resting ECG Devices
      • 6.3.1.2. Stress ECG Devices
    • 6.3.2. Holter Monitors
    • 6.3.3. Event Monitors
    • 6.3.4. Implantable Loop Recorders
    • 6.3.5. Mobile Cardiac Telemetry
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Ambulatory Surgery Centers
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. ECG Devices
      • 9.2.1.1. Resting ECG Devices
      • 9.2.1.2. Stress ECG Devices
    • 9.2.2. Holter Monitors
    • 9.2.3. Event Monitors
    • 9.2.4. Implantable Loop Recorders
    • 9.2.5. Mobile Cardiac Telemetry
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Ambulatory Surgery Centers
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. ECG Devices
      • 10.2.1.1. Resting ECG Devices
      • 10.2.1.2. Stress ECG Devices
    • 10.2.2. Holter Monitors
    • 10.2.3. Event Monitors
    • 10.2.4. Implantable Loop Recorders
    • 10.2.5. Mobile Cardiac Telemetry
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Clinics
    • 10.3.3. Ambulatory Surgery Centers
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. ECG Devices
      • 11.2.1.1. Resting ECG Devices
      • 11.2.1.2. Stress ECG Devices
    • 11.2.2. Holter Monitors
    • 11.2.3. Event Monitors
    • 11.2.4. Implantable Loop Recorders
    • 11.2.5. Mobile Cardiac Telemetry
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Clinics
    • 11.3.3. Ambulatory Surgery Centers
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. ECG Devices
      • 12.2.1.1. Resting ECG Devices
      • 12.2.1.2. Stress ECG Devices
    • 12.2.2. Holter Monitors
    • 12.2.3. Event Monitors
    • 12.2.4. Implantable Loop Recorders
    • 12.2.5. Mobile Cardiac Telemetry
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Clinics
    • 12.3.3. Ambulatory Surgery Centers
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. ECG Devices
      • 13.2.1.1. Resting ECG Devices
      • 13.2.1.2. Stress ECG Devices
    • 13.2.2. Holter Monitors
    • 13.2.3. Event Monitors
    • 13.2.4. Implantable Loop Recorders
    • 13.2.5. Mobile Cardiac Telemetry
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Clinics
    • 13.3.3. Ambulatory Surgery Centers
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Competitive Business Strategies
  • 14.4. Company Profiles
    • 14.4.1. Abbott Laboratories
      • 14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.1.2. Company Financials
      • 14.4.1.3. Growth Strategies
      • 14.4.1.4. SWOT Analysis
    • 14.4.2. Biotronik
      • 14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.2.2. Company Financials
      • 14.4.2.3. Growth Strategies
      • 14.4.2.4. SWOT Analysis
    • 14.4.3. Boston Scientific Corporation
      • 14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.3.2. Company Financials
      • 14.4.3.3. Growth Strategies
      • 14.4.3.4. SWOT Analysis
    • 14.4.4. GE Healthcare
      • 14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.4.2. Company Financials
      • 14.4.4.3. Growth Strategies
      • 14.4.4.4. SWOT Analysis
    • 14.4.5. Medtronic
      • 14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.5.2. Company Financials
      • 14.4.5.3. Growth Strategies
      • 14.4.5.4. SWOT Analysis
    • 14.4.6. Nihon Kohden Corporation
      • 14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.6.2. Company Financials
      • 14.4.6.3. Growth Strategies
      • 14.4.6.4. SWOT Analysis